KPIs & Operating Metrics(New)
Adjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By Segment %Adjusted Ebitda Margin By Segment Annual %Average Pmpm By Product TypeAverage Pmpm Fees / Revenue Per Case By SegmentAverage Unique MembersAverage Unique Members AnnualAverage Yield Per CaseBreakdown Of AssetsContractual ObligationsCost Of RevenueDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionLives By Product TypeLives Managed By SegmentLives On Platform/ Cases During Period By SegmentNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total Revenue %OPEX SegregationProperty And Equipment, NetRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By End MarketRevenue By End Market %Revenue By End Market AnnualRevenue By End Market Annual %Revenue By Product TypeRevenue By Product Type %Revenue By Product Type AnnualRevenue By Product Type Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Cases ManagedTotal Lives ManagedTotal Lives On Platform
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Gross Profit (2023 - 2025)

Evolent Health has reported Gross Profit over the past 11 years, most recently at $97.3 million for Q4 2025.

  • Quarterly results put Gross Profit at $97.3 million for Q4 2025, up 28.45% from a year ago — trailing twelve months through Dec 2025 was $399.9 million (up 8.86% YoY), and the annual figure for FY2025 was $399.9 million, up 8.86%.
  • Gross Profit for Q4 2025 was $97.3 million at Evolent Health, down from $99.8 million in the prior quarter.
  • Over the last five years, Gross Profit for EVH hit a ceiling of $124.4 million in Q3 2023 and a floor of $49.9 million in Q2 2021.
  • Median Gross Profit over the past 5 years was $91.6 million (2022), compared with a mean of $89.7 million.
  • Biggest five-year swings in Gross Profit: surged 66.87% in 2023 and later crashed 35.15% in 2024.
  • Evolent Health's Gross Profit stood at $83.9 million in 2021, then decreased by 0.97% to $83.1 million in 2022, then increased by 22.35% to $101.6 million in 2023, then decreased by 25.5% to $75.7 million in 2024, then grew by 28.45% to $97.3 million in 2025.
  • The last three reported values for Gross Profit were $97.3 million (Q4 2025), $99.8 million (Q3 2025), and $100.4 million (Q2 2025) per Business Quant data.